Preoperative Vitamin K Reduces Blood Transfusions at Time of Left Ventricular Assist Device Implant.
Congestive heart failure patients have hepatic congestion and abnormal coagulation profiles, increasing perioperative bleeding at time of implantation of ventricular assist device. The aim of this study was to examine the impact of preoperative administration of vitamin K on perioperative blood transfusion requirements. Retrospectively, 190 patients met inclusion criteria. Patients received no vitamin K (n=62) or two 10-mg doses of intravenous vitamin K (n=128) in the 24 hours prior to assist device implantation. Primary endpoints included transfusion requirements and reexploration rates for bleeding. Secondary outcomes were pump thrombosis and in-hospital mortality. Baseline characteristics were similar between the two groups with slight differences (not statistically significant) noted in the Interagency Registry for Mechanically Assisted Circulatory Support profile and total bilirubin levels. nly significant difference noted was the year of implantation (p<0.0001). Blood product usage was significantly lower in the vitamin K group compared to the no vitamin K group (p<0.0001). Higher rates of reexploration for bleeding (29.7% vs 13.6%, p=0.023) and death at hospital discharge (16.2% vs 2.8%, p=0.004 were noted for the no vitamin K group compared to the vitamin K group. After adjusting for age, gender, race, BMI, Interagency Registry for Mechanically Assisted Circulatory Support profile, total bilirubin, surgeon, and year of surgery, reexploration rates and death did not achieve statistical significance. No statistically significant difference observed in stroke and pump thrombosis rates between two groups. Preoperative vitamin K administration may help reduce blood product utilization without any increased risk for strokes or pump thrombosis.